Zhenyan Hou

460 total citations
21 papers, 371 citations indexed

About

Zhenyan Hou is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Zhenyan Hou has authored 21 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Pharmacology and 7 papers in Complementary and alternative medicine. Recurrent topics in Zhenyan Hou's work include Natural Compounds in Disease Treatment (7 papers), Pharmacological Effects of Natural Compounds (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Zhenyan Hou is often cited by papers focused on Natural Compounds in Disease Treatment (7 papers), Pharmacological Effects of Natural Compounds (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Zhenyan Hou collaborates with scholars based in China. Zhenyan Hou's co-authors include Miao Yan, Pingfei Fang, Bikui Zhang, Yongbo Peng, Miao Yan, Ling-Juan Cao, Sisi Cao, Lin Guo, Hui Gong and Yang Deng and has published in prestigious journals such as International Journal of Molecular Sciences, Cellular and Molecular Life Sciences and Journal of Ethnopharmacology.

In The Last Decade

Zhenyan Hou

20 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenyan Hou China 12 160 132 94 52 41 21 371
Sixi Zhang China 11 166 1.0× 69 0.5× 78 0.8× 56 1.1× 50 1.2× 16 402
Yushi Zhang China 12 101 0.6× 50 0.4× 114 1.2× 65 1.3× 38 0.9× 42 411
Fujing Wang China 11 165 1.0× 49 0.4× 59 0.6× 54 1.0× 63 1.5× 24 381
Jiajie Luan China 14 205 1.3× 58 0.4× 37 0.4× 77 1.5× 49 1.2× 31 505
Feixia Dong China 6 173 1.1× 46 0.3× 124 1.3× 37 0.7× 35 0.9× 8 518
Jingzhuo Tian China 12 129 0.8× 70 0.5× 154 1.6× 115 2.2× 35 0.9× 38 438
Qingyu Zhang China 13 198 1.2× 47 0.4× 54 0.6× 72 1.4× 47 1.1× 27 454
Jiarong Gao China 14 250 1.6× 102 0.8× 79 0.8× 19 0.4× 52 1.3× 55 485
Zhou Liu China 9 97 0.6× 70 0.5× 41 0.4× 35 0.7× 47 1.1× 21 374
Feifei Cai China 12 164 1.0× 66 0.5× 131 1.4× 30 0.6× 148 3.6× 29 441

Countries citing papers authored by Zhenyan Hou

Since Specialization
Citations

This map shows the geographic impact of Zhenyan Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenyan Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenyan Hou more than expected).

Fields of papers citing papers by Zhenyan Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenyan Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenyan Hou. The network helps show where Zhenyan Hou may publish in the future.

Co-authorship network of co-authors of Zhenyan Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenyan Hou. A scholar is included among the top collaborators of Zhenyan Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenyan Hou. Zhenyan Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Mingjin, Zhenyan Hou, Weida Wang, et al.. (2024). ACAT1 Induces the Differentiation of Glioblastoma Cells by Rewiring Choline Metabolism. International Journal of Biological Sciences. 20(14). 5576–5593. 1 indexed citations
2.
Du, Tingting, Xiaowen Hu, Zhenyan Hou, et al.. (2024). Re-expression of epigenetically silenced PTPRR by histone acetylation sensitizes RAS-mutant lung adenocarcinoma to SHP2 inhibition. Cellular and Molecular Life Sciences. 81(1). 64–64.
3.
Wang, Weida, Mingjin Wang, Tingting Du, et al.. (2023). SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling. International Journal of Molecular Sciences. 24(8). 7150–7150. 18 indexed citations
4.
Hou, Zhenyan, Miao Yan, Huixiang Li, et al.. (2023). Variable p53/Nrf2 crosstalk contributes to triptolide-induced hepatotoxic process. Toxicology Letters. 379. 67–75. 4 indexed citations
5.
Wang, Mingjin, Zhenyan Hou, Weida Wang, et al.. (2023). Chlorogenic Acid Induced Neuroblastoma Cells Differentiation via the ACAT1-TPK1-PDH Pathway. Pharmaceuticals. 16(6). 877–877. 8 indexed citations
6.
Hou, Zhenyan, Songwen Lin, Tingting Du, et al.. (2023). S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer. Pharmaceuticals. 16(5). 749–749. 2 indexed citations
7.
Wang, Mingjin, Weida Wang, Zhenyan Hou, et al.. (2023). ACAT1 deficiency in myeloid cells promotes glioblastoma progression by enhancing the accumulation of myeloid-derived suppressor cells. Acta Pharmaceutica Sinica B. 13(12). 4733–4747. 12 indexed citations
8.
Yan, Miao, Lin Guo, Yan Yang, et al.. (2021). Glycyrrhetinic Acid Protects α-Naphthylisothiocyanate- Induced Cholestasis Through Regulating Transporters, Inflammation and Apoptosis. Frontiers in Pharmacology. 12. 701240–701240. 22 indexed citations
9.
Li, Yao, et al.. (2021). Role of MicroRNA-155 in Triptolide-induced hepatotoxicity via the Nrf2-Dependent pathway. Journal of Ethnopharmacology. 281. 114489–114489. 20 indexed citations
10.
Zhang, Huimin, Min Zhang, Hui Xie, et al.. (2020). Celastrol slows the progression of early diabetic nephropathy in rats via the PI3K/AKT pathway. BMC Complementary Medicine and Therapies. 20(1). 321–321. 31 indexed citations
11.
Hou, Zhenyan, et al.. (2018). Broad targeting of triptolide to resistance and sensitization for cancer therapy. Biomedicine & Pharmacotherapy. 104. 771–780. 49 indexed citations
12.
Chen, Ying, Yang Deng, Miao Yan, et al.. (2018). Genotyping as a Key Element of Sample Size Optimization in Bioequivalence of Risperidone Tablets. European Journal of Drug Metabolism and Pharmacokinetics. 43(4). 431–439. 4 indexed citations
13.
Hou, Zhenyan, Lei Chen, Pingfei Fang, et al.. (2018). Mechanisms of Triptolide-Induced Hepatotoxicity and Protective Effect of Combined Use of Isoliquiritigenin: Possible Roles of Nrf2 and Hepatic Transporters. Frontiers in Pharmacology. 9. 226–226. 46 indexed citations
14.
Hou, Zhenyan, Miao Yan, Hualin Cai, et al.. (2018). Simple and rapid UPLC-MS/MS method for quantification of entecavir in human plasma: Application to a bioequivalence study. International Journal of Clinical Pharmacology and Therapeutics. 56(4). 197–204. 2 indexed citations
15.
Yan, Miao, Lei Chen, Pingfei Fang, et al.. (2018). Nrf2‑dependent antioxidant response mediated the protective effect of tanshinone IIA on doxorubicin‑induced cardiotoxicity. Experimental and Therapeutic Medicine. 16(4). 3333–3344. 65 indexed citations
16.
Cao, Sisi, Miao Yan, Zhenyan Hou, et al.. (2017). Danshen modulates Nrf2-mediated signaling pathway in cisplatin-induced renal injury. Current Medical Science. 37(5). 761–765. 21 indexed citations
17.
Yan, Miao, et al.. (2017). Glycyrrhetinic Acid Accelerates the Clearance of Triptolide through P‐gp In Vitro. Phytotherapy Research. 31(7). 1090–1096. 24 indexed citations
18.
Cao, Ling-Juan, Zhenyan Hou, LI Huan-de, et al.. (2017). The Ethanol Extract of Licorice (Glycyrrhiza uralensis) Protects against Triptolide‐Induced Oxidative Stress through Activation of Nrf2. Evidence-based Complementary and Alternative Medicine. 2017(1). 2752389–2752389. 24 indexed citations
19.
Cao, Sisi, Pingfei Fang, Hualin Cai, et al.. (2017). Pharmacokinetics and relative bioavailability of a generic amisulpride tablet in healthy Chinese volunteers. International Journal of Clinical Pharmacology and Therapeutics. 55(10). 825–831. 4 indexed citations
20.
Li, Zhihua, Yang Deng, Hualin Cai, et al.. (2016). Pharmacokinetic properties and bioequivalence of spironolactone tablets in fasting and fed healthy Chinese male subjects. International Journal of Clinical Pharmacology and Therapeutics. 54(6). 455–461. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sixi Zhang Breakdown of academic impact, for papers by Yushi Zhang Breakdown of academic impact, for papers by Fujing Wang Breakdown of academic impact, for papers by Jiajie Luan Breakdown of academic impact, for papers by Feixia Dong Breakdown of academic impact, for papers by Jingzhuo Tian Breakdown of academic impact, for papers by Qingyu Zhang Breakdown of academic impact, for papers by Jiarong Gao Breakdown of academic impact, for papers by Zhou Liu Breakdown of academic impact, for papers by Feifei Cai
Rankless by CCL
2026